Menu
Back to User profile » Dr Valentina Perrone
Papers published by Dr Valentina Perrone:
Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis
Nava FA, Mangia A, Riglietta M, Somaini L, Foschi FG, Claar E, Maida I, Ucciferri C, Frigerio F, Hernandez C, Dovizio M, Perrone V, Degli Esposti L, Puoti M
Therapeutics and Clinical Risk Management 2023, 19:645-656
Published Date: 4 August 2023
Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population
Perrone V, Losi S, Sabatino S, Mezzetti M, Dovizio M, Sangiorgi D, Degli Esposti L
Psoriasis: Targets and Therapy 2023, 13:1-9
Published Date: 2 March 2023
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
Fagiuoli S, Toniutto P, Coppola N, Ancona DD, Andretta M, Bartolini F, Ferrante F, Lupi A, Palcic S, Rizzi FV, Re D, Alvarez Nieto G, Hernandez C, Frigerio F, Perrone V, Degli Esposti L, Mangia A
Therapeutics and Clinical Risk Management 2023, 19:57-65
Published Date: 18 January 2023
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
Perrone V, Veronesi C, Giacomini E, Citraro R, Dell'Orco S, Lena F, Paciello A, Resta AM, Nica M, Ritrovato D, Degli Esposti L
Clinical Epidemiology 2022, 14:1327-1337
Published Date: 6 November 2022
Evaluation of the Therapeutic Pattern and Pharmaco-Utilization in Hypercholesterolemic Patients Treated with Statins: A Retrospective Study on Italian Real-World Data
Perrone V, Giacomini E, Sangiorgi D, Andretta M, Bartolini F, Lupi A, Ferrante F, Palcic S, Re D, Degli Esposti L
Risk Management and Healthcare Policy 2022, 15:1483-1489
Published Date: 28 July 2022
Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources
Perrone V, Veronesi C, Dovizio M, Ancona DD, Andretta M, Bartolini F, Cavaliere A, Chinellato A, Ciaccia A, Cillo M, De Francesco A, Enieri N, Ferrante F, Gentile S, Procacci C, Ubertazzo L, Vercellone A, Lucatelli D, Procaccini M, Degli Esposti L
ClinicoEconomics and Outcomes Research 2022, 14:513-521
Published Date: 28 July 2022
Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy
Degli Esposti L, Veronesi C, Ancona DD, Andretta M, Bartolini F, Drei A, Lupi A, Palcic S, Re D, Rizzi FV, Giacomini E, Perrone V
ClinicoEconomics and Outcomes Research 2022, 14:139-147
Published Date: 10 March 2022
Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy
Perrone V, Sangiorgi D, Andretta M, Ducci G, Forti B, Francesa Morel PC, Gambera M, Maina G, Mencacci C, Mennini FS, Zanalda E, Degli Esposti L
ClinicoEconomics and Outcomes Research 2021, 13:629-635
Published Date: 5 July 2021
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia
Perrone V, Giacomini E, Andretta M, Arenare L, Cillo MR, Latini M, Mecozzi A, Pagliaro R, Vercellone A, Degli Esposti L
Therapeutics and Clinical Risk Management 2021, 17:617-622
Published Date: 8 June 2021
Evidence of Antibiotic Resistance from Population-Based Studies: A Narrative Review
Giacomini E, Perrone V, Alessandrini D, Paoli D, Nappi C, Degli Esposti L
Infection and Drug Resistance 2021, 14:849-858
Published Date: 3 March 2021
Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project
Degli Esposti L, Buda S, Nappi C, Paoli D, Perrone V
Risk Management and Healthcare Policy 2020, 13:3179-3185
Published Date: 30 December 2020
Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
Perrone V, Giacomini E, Sangiorgi D, Andretta M, Menti AM, Naclerio M, Ritrovato D, Degli Esposti L
Therapeutics and Clinical Risk Management 2020, 16:509-521
Published Date: 9 June 2020
Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis
Perrone V, Degli Esposti L, Giacomini E, Veronesi C, Blini V, Oderda M
Therapeutics and Clinical Risk Management 2020, 16:393-401
Published Date: 7 May 2020
Economic Burden of Osteoporotic Patients with Fracture: Effect of Treatment With or Without Calcium/Vitamin D Supplements
Degli Esposti L, Saragoni S, Perrone V, Sella S, Andretta M, Rossini M, Giannini S
Nutrition and Dietary Supplements 2020, 12:21-30
Published Date: 20 February 2020
Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases
Degli Esposti L, Andretta M, Di Pasquale G, Gambera M, Saragoni S, Perrone V, Buda S
Vascular Health and Risk Management 2019, 15:429-437
Published Date: 11 October 2019
Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital
Perrone V, Veronesi C, Nica M, Colombo D, Degli Esposti L, Castello R
Therapeutics and Clinical Risk Management 2019, 15:847-850
Published Date: 8 July 2019
Therapeutic strategies utilization and resource consumption in patients treated for psoriatic arthritis: findings from a real-world analysis in an Italian setting
Degli Esposti L, Perrone V, Sangiorgi D, Alessandrini D, Buda S, Cantini F, Mazzini E, Toma C, De Solda F
Patient Preference and Adherence 2019, 13:187-194
Published Date: 22 January 2019
All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R
Vascular Health and Risk Management 2018, 14:383-392
Published Date: 20 November 2018
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
Degli Esposti L, Perrone V, Sangiorgi D, Buda S, Andretta M, Rossini M, Girolomoni G
Biologics: Targets and Therapy 2018, 12:151-158
Published Date: 12 November 2018
Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
Fakhouri W, Lopez-Romero P, Antonelli S, Losi S, Rogai V, Buda S, Sangiorgi D, Perrone V, Degli Esposti L
Open Access Rheumatology: Research and Reviews 2018, 10:103-111
Published Date: 10 August 2018
Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L
ClinicoEconomics and Outcomes Research 2017, 9:609-616
Published Date: 10 October 2017
Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G
Vascular Health and Risk Management 2017, 13:239-246
Published Date: 5 July 2017
Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
Degli Esposti L, Veronesi C, Perrone V, Buda S, Santoro A
ClinicoEconomics and Outcomes Research 2017, 9:233-239
Published Date: 27 April 2017
Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2017, 9:181-188
Published Date: 6 March 2017
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:227-228
Published Date: 10 January 2017
Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimiliars
Perrone V, Saragoni S, Buda S, Broccoli A, Degli Esposti L
Biologics: Targets and Therapy 2016, 10:157-165
Published Date: 1 December 2016
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2749-2755
Published Date: 4 November 2016
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:649-655
Published Date: 25 October 2016
Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:591-597
Published Date: 14 October 2016